Canopy Growth (CGC) to Release Earnings on Friday

Canopy Growth (NASDAQ:CGCGet Free Report) is expected to be issuing its Q3 2026 results before the market opens on Friday, February 6th. Analysts expect the company to announce earnings of ($0.03) per share and revenue of $70.9570 million for the quarter. Individuals may visit the the company’s upcoming Q3 2026 earning results page for the latest details on the call scheduled for Friday, February 6, 2026 at 10:00 AM ET.

Canopy Growth (NASDAQ:CGCGet Free Report) last released its quarterly earnings data on Friday, November 7th. The company reported ($0.01) EPS for the quarter, beating analysts’ consensus estimates of ($0.11) by $0.10. Canopy Growth had a negative net margin of 113.21% and a negative return on equity of 61.97%. The business had revenue of $47.86 million during the quarter, compared to analysts’ expectations of $71.82 million. On average, analysts expect Canopy Growth to post $-3 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Canopy Growth Stock Down 0.9%

NASDAQ:CGC opened at $1.16 on Thursday. Canopy Growth has a 1 year low of $0.77 and a 1 year high of $2.90. The company has a current ratio of 5.50, a quick ratio of 4.23 and a debt-to-equity ratio of 0.31. The stock has a market cap of $427.41 million, a price-to-earnings ratio of -0.59 and a beta of 0.56. The stock has a 50-day moving average price of $1.25 and a two-hundred day moving average price of $1.29.

Institutional Trading of Canopy Growth

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Two Sigma Investments LP acquired a new position in shares of Canopy Growth during the 3rd quarter worth about $1,767,000. UBS Group AG lifted its stake in Canopy Growth by 32.1% in the 3rd quarter. UBS Group AG now owns 575,107 shares of the company’s stock valued at $840,000 after purchasing an additional 139,725 shares during the last quarter. Mackenzie Financial Corp grew its holdings in Canopy Growth by 33.1% during the third quarter. Mackenzie Financial Corp now owns 111,945 shares of the company’s stock worth $163,000 after purchasing an additional 27,823 shares during the period. Two Sigma Securities LLC increased its position in Canopy Growth by 4.4% during the second quarter. Two Sigma Securities LLC now owns 280,852 shares of the company’s stock worth $343,000 after buying an additional 11,942 shares during the last quarter. Finally, Murchinson Ltd. acquired a new position in Canopy Growth during the second quarter worth approximately $183,000. 3.33% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

CGC has been the topic of a number of research analyst reports. Benchmark upgraded shares of Canopy Growth from a “sell” rating to a “hold” rating in a report on Monday, November 10th. Alliance Global Partners reaffirmed a “neutral” rating on shares of Canopy Growth in a research note on Monday, December 15th. Weiss Ratings reissued a “sell (e+)” rating on shares of Canopy Growth in a research report on Wednesday, January 21st. Finally, Wall Street Zen upgraded shares of Canopy Growth from a “sell” rating to a “hold” rating in a report on Saturday, November 8th. Three analysts have rated the stock with a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Reduce”.

Check Out Our Latest Research Report on CGC

About Canopy Growth

(Get Free Report)

Canopy Growth Corporation is a leading Canadian cannabis company engaged in the production, distribution and sale of both medical and recreational cannabis products. Headquartered in Smiths Falls, Ontario, the company cultivates a diversified portfolio of offerings that includes dried flower, pre-rolled joints, oils, softgel capsules and edibles. Canopy Growth also markets derivative products such as beverages and wellness formulations under a range of brands, aiming to serve both patient and adult-use markets.

The company operates through multiple subsidiaries, including Tweed Inc, Spectrum Therapeutics and Tokyo Smoke, each targeting distinct consumer segments.

See Also

Earnings History for Canopy Growth (NASDAQ:CGC)

Receive News & Ratings for Canopy Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canopy Growth and related companies with MarketBeat.com's FREE daily email newsletter.